Related Experiment Video
Updated: Aug 7, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Gene therapy for brain tumors: the fundamentals
1Departments of Neurosurgery and Molecular Genetics, The University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Surgical Neurology
|October 12, 2000
Summary
Brain tumor gene therapy, including suicide gene therapy, shows promise and is generally safe. While not yet curative, it remains an important experimental option for malignant brain tumors.
Area of Science:
- Virology and molecular biology advancements.
- Understanding genetic alterations in brain tumors.
Background:
- Significant progress in virology and molecular biology over 20 years.
- Application of this knowledge to brain tumor gene therapy.
Purpose of the Study:
- Introduce brain tumor gene therapy to clinicians.
- Provide an overview of current strategies and safety.
Main Methods:
- Overview of five main gene therapy categories for brain tumors:
- Gene-directed enzyme prodrug (GDEPT) therapy (suicide gene therapy).
- Immune-boosting gene therapy.
- Oncolytic virus therapy.
- Therapeutic gene transfer (e.g., tumor suppressor genes).
- Antisense therapy.
Main Results:
- Gene therapy strategies have been utilized in laboratory and clinical settings.
- Gene-directed enzyme prodrug therapy is the most studied approach.
- Current gene therapy approaches are generally safe.
- Concerns like insertional mutagenesis have not materialized.
Conclusions:
- Brain tumor gene therapy is in its early stages of development.
- No cures have been achieved yet.
- Research is ongoing to overcome clinical application limitations.
- Gene therapy is an intriguing experimental option for malignant brain tumors.
